2019 New French DRGs Tariffs
15 mars 2019
1 min de lecture
Dernière mise à jour : 29 mars 2019
In the reimbursement world, there are good news for French Hospitals and market access managers! Indeed, in March 2019, both public and private hospitals DRGs tariffs increased after several years of cuts trend. Below are some statistics / analytics. Source : ATIH
Follow us on LinkedIn : https://lnkd.in/dfQ6ckS
Cuts in inpatient DRGs but increases in outpatient setting
We observed severe cuts in some level1 DRGs tariffs (ie : Tumeurs de la peau or Skin Tumors) that were compensated by outpatients DRGs tariffs increases. Below the TOP20 cuts in public hospitals. Contact us to get our full analysis in English or French. Source : ATIH
This insightful healthcare economics and regulatory feature from IHMT Medical Device (2019 France DRGs GHS Tariffs) highlights the vital intersection of medical device reimbursement, hospital financing systems, and European healthcare policy—themes that find great synergy with health economics guides, regulatory compliance spotlights, and medical technology chronicles, published on https://34.ua. The piece examines the structural details of the French Diagnosis-Related Group (DRG/GHS) tariff system, detailing how pricing frameworks impact healthcare providers, medical device manufacturers, and patient access to advanced hospital technologies.